Selected article for: "model development and public health"

Author: Totura, Allison; Livingston, Virginia; Frick, Ondraya; Dyer, David; Nichols, Donald; Nalca, Aysegul
Title: Small Particle Aerosol Exposure of African Green Monkeys to MERS-CoV as a Model for Highly Pathogenic Coronavirus Infection
  • Cord-id: vknjdmh4
  • Document date: 2020_12_25
  • ID: vknjdmh4
    Snippet: Emerging coronaviruses are a global public health threat because of the potential for person-to-person transmission and high mortality rates. Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in 2012, causing lethal respiratory disease in »35% of cases. Primate models of coronavirus disease are needed to support development of therapeutics, but few models exist that recapitulate severe disease. For initial development of a MERS-CoV primate model, 12 African green monkeys were expo
    Document: Emerging coronaviruses are a global public health threat because of the potential for person-to-person transmission and high mortality rates. Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in 2012, causing lethal respiratory disease in »35% of cases. Primate models of coronavirus disease are needed to support development of therapeutics, but few models exist that recapitulate severe disease. For initial development of a MERS-CoV primate model, 12 African green monkeys were exposed to 10(3), 10(4), or 10(5) PFU target doses of aerosolized MERS-CoV. We observed a dose-dependent increase of respiratory disease signs, although all 12 monkeys survived for the 28-day duration of the study. This study describes dose-dependent effects of MERS-CoV infection of primates and uses a route of infection with potential relevance to MERS-CoV transmission. Aerosol exposure of African green monkeys might provide a platform approach for the development of primate models of novel coronavirus diseases.

    Search related documents:
    Co phrase search for related documents
    • acute phase and liver damage indicative: 1
    • acute phase and lung dysfunction: 1, 2, 3, 4, 5, 6, 7
    • acute phase and lung lesion: 1
    • acute time and additional contact: 1
    • acute time and liver damage: 1
    • acute time and lung dysfunction: 1
    • liver damage and lung dysfunction: 1, 2